Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)
Saved in:
| Title: | Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT) |
|---|---|
| Authors: | Antoni CE (AUTHOR), Kavanaugh A (AUTHOR), Kirkham B (AUTHOR), Tutuncu Z (AUTHOR), Burmester GR (AUTHOR), Schneider U (AUTHOR), Furst DE (AUTHOR), Molitor J (AUTHOR), Keystone E (AUTHOR), Gladman D (AUTHOR), Manger B (AUTHOR), Wassenberg S (AUTHOR), Weier R (AUTHOR), Wallace DJ (AUTHOR), Weisman MH (AUTHOR), Kalden JR (AUTHOR), Smolen J (AUTHOR) |
| Source: | Arthritis & Rheumatism. Apr2005, Vol. 52 Issue 4, p1227-1236. 10p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00043591 |
|---|---|
| DOI: | 10.1002/art.20967 |
